slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 40,711-40,740
Pages 10,126
Rows per page 30
Component
40,711-40,740 of 303,780
11
Includes specific performance metrics for organic growth and operating margin.3M | Results Presentation Deck | 20 slides · 3M
Conference presentation Investor relations 2 hits
01
AbCellera | Investor Conference Presentation Deck | 19 slidesAbCellera | Investor Conference Presentation Deck | 19 slides · AbCellera
Conference presentation Investor relations Beat · Situation & Context2 hits
08
AbCellera | Investor Conference Presentation Deck | 19 slidesAbCellera | Investor Conference Presentation Deck | 19 slides · AbCellera
Conference presentation Investor relations Beat · Solution & Approach2 hits
09
The slide uses a card-based layout to categorize three types of programs: Discovery, Co-Development, and Pre-Partnered.AbCellera | Investor Conference Presentation Deck | 19 slides · AbCellera
Conference presentation Investor relations Beat · Solution & Approach2 hits
10
Part of a series of slides defining business model segments.AbCellera | Investor Conference Presentation Deck | 19 slides · AbCellera
Conference presentation Investor relations Beat · Evidence & Proof2 hits
11
The slide uses a green callout box to emphasize the deal structure.AbCellera | Investor Conference Presentation Deck | 19 slides · AbCellera
Conference presentation Investor relations Beat · Evidence & Proof2 hits
12
AbCellera | Investor Conference Presentation Deck | 19 slidesAbCellera | Investor Conference Presentation Deck | 19 slides · AbCellera
Conference presentation Investor relations Beat · Evidence & Proof2 hits
16
The slide uses a circular arc diagram to connect the two main pillars of capital allocation to their respective sub-activities.AbCellera | Investor Conference Presentation Deck | 19 slides · AbCellera
Conference presentation Investor relations Beat · Impact & Next Steps2 hits
17
The diagram uses a central hub-and-spoke style structure with a surrounding circular path of secondary factors.AbCellera | Investor Conference Presentation Deck | 19 slides · AbCellera
Conference presentation Investor relations Beat · Impact & Next Steps2 hits
19
AbCellera | Investor Conference Presentation Deck | 19 slidesAbCellera | Investor Conference Presentation Deck | 19 slides · AbCellera
Conference presentation Investor relations Beat · Impact & Next Steps2 hits
04
Absci | Investor Presentation Deck | 27 slidesAbsci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · SetupLoop · Golden Circle2 hits
05
The diagram illustrates the iterative, inefficient nature of conventional drug discovery (immunization/phage display) leading to suboptimal candidates.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction2 hits
06
The slide uses a two-column bulleted list to contrast the general AI drug discovery market with Absci's specific focus on biologics.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction2 hits
07
The slide uses a two-column bulleted list to contrast traditional methods with their AI-driven approach and the resulting benefits.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle2 hits
09
The slide uses a metaphor of 'creating the needle' rather than 'finding it in a haystack' to describe their AI-driven drug design process.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle2 hits
10
The slide highlights six specific parameters: Target, Affinity, Epitope, Developability, Manufacturability, and Immunogenicity.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · Solution2 hits
11
The slide uses a circular process diagram to represent the flywheel effect of their platform.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · Solution2 hits
12
Uses a comparison framework to contrast data availability between small molecules and biologics.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · Evidence2 hits
13
The slide uses a process flow diagram to illustrate the transition from biological wet-lab data generation to AI model training.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · Evidence2 hits
14
The slide uses a linear process flow to demonstrate the end-to-end nature of the platform.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · Evidence2 hits
15
The diagram is a circular flywheel process showing the integration of data, wet lab validation, and AI creation.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · Action2 hits
18
The slide uses a four-column layout to categorize value propositions, each supported by a visual icon or diagram.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · Action2 hits
19
Uses a timeline comparison to illustrate value proposition.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · Action2 hits
20
The chart uses a dot-plot visualization to represent cash flow magnitude over time, categorized by development stages.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · ActionLoop · Before After2 hits
24
Includes a 'Chief Morale Officer' (a dog) as a lighthearted team member.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · Action2 hits
25
Includes a Kaplan-Meier survival curve and a comparative table of clinical outcomes.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations 2 hits
35
The slide uses a flow diagram to illustrate the randomization process and study timeline.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations 2 hits
36
The table highlights specific clinical response metrics for six individual patients, demonstrating improvements and normalization of mobility scores.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations 2 hits
15
Alkermes | Results Presentation Deck | 21 slidesAlkermes | Results Presentation Deck | 21 slides · Alkermes
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction2 hits
12
The chart shows negative cash flow values improving over time.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · Long-Term GoalLoop · Cost Of Inaction2 hits